Skip to main content

SYNAPTICS Inc

For the period ended Jun 27, 2026. Filed Aug 10, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Aug 10, 2026

SYNA$117.25+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

(in millions, except par value and share amounts)

June2026June2025
ASSETS
Current Assets:
Cash and cash equivalents$442.5$391.5
Short-term investments—61.0
Receivables, net164.0130.3
Inventories156.4139.5
Prepaid expenses and other current assets24.129.6
Total current assets787.0751.9
Property and equipment, net86.972.1
Goodwill872.3872.3
Acquired intangible assets187.8262.2
Deferred tax assets6.2408.8
Non-current other assets161.8217.1
Total assets$2,102.0$2,584.4
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable$82.6$98.5
Accrued liabilities179.1172.4
Current portion of long-term debt439.6—
Total current liabilities701.3270.9
Long-term debt397.7834.8
Other long-term liabilities73.583.8
Total liabilities1,172.51,189.5
Stockholders’ Equity:
Preferred stock:
$0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding——
Common stock:
$0.001 par value; 120,000,000 shares authorized; 72,350,090 and 70,611,845 shares issued, 39,062,676 and 38,642,761 shares outstanding, at June 2026 and June 2025, respectively0.10.1
Additional paid-in capital1,329.91,211.8
Treasury stock: 33,287,414 and 31,969,084 common shares at June 2026 and June 2025, respectively, at cost(1,099.6)(1,006.9)
Retained earnings699.11,189.9
Total stockholders’ equity929.51,394.9
Total liabilities and stockholders’ equity$2,102.0$2,584.4
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.